RH Capital announces investments to improve women’s health
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
This agreement is in addition to the $92 million filling line expansion announced in November 2021
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
Digital PCR format allows for rapid turnaround time to facilitate fast and accurate post-transplant treatment decisions
Funds will be allocated to accelerate rapid production and high-end curation of whole genome sequences for its clinical application
Star Array's focus has been on the development of an automated (cassette-based) nucleic acid purification system coupled with its superfast nucleic acid amplification technology
Strive to empower public health with disinfection robotics solutions in post-pandemic era
Subscribe To Our Newsletter & Stay Updated